ICD-10

ICD-10 code C92.0

You are here: Home > ICD-10-CM > C00-D49 > C00-C96 > C81-C96 > C92

- ICD-10-CM
TABULAR LIST of DISEASES and INJURIES
- C00-D49
Neoplasms
- C00-C96
Malignant neoplasms
- C81-C96
Malignant neoplasms of lymphoid, hematopoietic and related tissue
- C92
Myeloid leukemia

C92.0

Acute myeloblastic leukemia

ICD-10 code C92.0 for Acute myeloblastic leukemia

Acute myeloblastic leukemia, minimal differentiation
Acute myeloblastic leukemia (with maturation)
Acute myeloblastic leukemia 1/ETO
Acute myeloblastic leukemia M0
Acute myeloblastic leukemia M1
Acute myeloblastic leukemia M2
Acute myeloblastic leukemia with t(8;21)
Acute myeloblastic leukemia (without a FAB classification) NOS
Refractory anemia with excess blasts in transformation [RAEB T]
Excludes1: acute exacerbation of chronic myeloid leukemia (C92.10)
refractory anemia with excess of blasts not in transformation (D46.2-)
C92.00
Acute myeloblastic leukemia, not having achieved remission
C92.01
Acute myeloblastic leukemia, in remission
C92.02
Acute myeloblastic leukemia, in relapse
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us